The SLC22 family with transporters of organic cations, anions and zwitterions

被引:307
作者
Koepsell, Hermann [1 ]
机构
[1] Univ Wurzburg, Inst Anat & Cell Biol, Koellikerstr 6, D-97070 Wurzburg, Germany
基金
瑞士国家科学基金会;
关键词
Drug transporter; Cation transporter; Anion transporter; Urate transporter; SLC22; Drug excretion; MESSENGER-RNA EXPRESSION; KIDNEY-SPECIFIC EXPRESSION; DRUG UPTAKE TRANSPORTERS; BLOOD-BRAIN-BARRIER; CARNITINE TRANSPORTER; MOLECULAR-CLONING; URIC-ACID; CATION/CARNITINE TRANSPORTERS; GENETIC-VARIATION; OCTN1; SLC22A4;
D O I
10.1016/j.mam.2012.10.010
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The SLC22 family contains 13 functionally characterized human plasma membrane proteins each with 12 predicted alpha-helical transmembrane domains. The family comprises organic cation transporters (OCTs), organic zwitterion/cation transporters (OCTNs), and organic anion transporters (OATs). The transporters operate as (1) uniporters which mediate facilitated diffusion (OCTs, OCTNs), (2) anion exchangers (OATs), and (3) Na+/zwitterion cotransporters (OCTNs). They participate in small intestinal absorption and hepatic and renal excretion of drugs, xenobiotics and endogenous compounds and perform homeostatic functions in brain and heart. Important endogeneous substrates include monoamine neurotransmitters, L-carnitine, alpha-ketoglutarate, cAMP, cGMP, prostaglandins, and urate. It has been shown that mutations of the SLC22 genes encoding these transporters cause specific diseases like primary systemic carnitine deficiency and idiopathic renal hypouricemia and are correlated with diseases such as Crohn's disease and gout. Drug-drug interactions at individual transporters may change pharmacokinetics and toxicities of drugs. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:413 / 435
页数:23
相关论文
共 202 条
[91]   Rosiglitazone for active ulcerative colitis: A randomized placebo-controlled trial [J].
Lewis, James D. ;
Lichtenstein, Gary R. ;
Deren, Julius J. ;
Sands, Bruce E. ;
Hanauer, Stephen B. ;
Katz, Jeffrey A. ;
Lashner, Bret ;
Present, Daniel H. ;
Chuai, Shaokun ;
Ellenbergr, Jonas H. ;
Nessel, Lisa ;
Wu, Gary D. .
GASTROENTEROLOGY, 2008, 134 (03) :688-695
[92]   Molecular Spectrum of SLC22A5 (OCTN2) Gene Mutations Detected in 143 Subjects Evaluated for Systemic Carnitine Deficiency [J].
Li, Fang-Yuan ;
El-Hattab, Ayman W. ;
Bawle, Erawati V. ;
Boles, Richard G. ;
Schmitt, Eric S. ;
Scaglia, Fernando ;
Wong, Lee-Jun .
HUMAN MUTATION, 2010, 31 (08) :E1632-E1651
[93]   Cellular localization of the organic cation transporters, OCT1 and OCT2, in brain microvessel endothelial cells and its implication for MPTP transport across the blood-brain barrier and MPTP-induced dopaminergic toxicity in rodents [J].
Lin, Chun-Jung ;
Tai, Ying ;
Huang, Miao-Tzu ;
Tsai, Yuan-Feen ;
Hsu, Hao-Jui ;
Tzen, Kai-Yuan ;
Liou, Horng-Huei .
JOURNAL OF NEUROCHEMISTRY, 2010, 114 (03) :717-727
[94]   Acute administration of cefepime lowers L-carnitine concentrations in early lactation stage rat milk [J].
Ling, Binbing ;
Alcorn, Jane .
JOURNAL OF NUTRITION, 2008, 138 (07) :1317-1322
[95]   Renal expression of organic anion transporter OAT2 in rats and mice is regulated by sex hormones [J].
Ljubojevic, Marija ;
Balen, Daniela ;
Breljak, Davorka ;
Kusan, Marija ;
Anzai, Naohiko ;
Bahn, Andrew ;
Burckhardt, Gerhard ;
Sabolic, Ivan .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2007, 292 (01) :F361-F372
[96]   cis-diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent:: Uptake, structure, function, and prospects [J].
Lovejoy, Katherine S. ;
Todd, Ryan C. ;
Zhang, Shuzhong ;
McCormick, Michael S. ;
D'Aquino, J. Alejandro ;
Reardon, Joyce T. ;
Sancar, Aziz ;
Giacomini, Kathleen M. ;
Lippard, Stephen J. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (26) :8902-8907
[97]   Mechanism of the regulation of organic cation/carnitine transporter 1 (SLC22A4) by rheumatoid arthritis-associated transcriptional factor RUNX1 and inflammatory cytokines [J].
Maeda, Tomoji ;
Hirayama, Masamichi ;
Kobayashi, Daisuke ;
Miyazawa, Keiji ;
Tamai, Ikumi .
DRUG METABOLISM AND DISPOSITION, 2007, 35 (03) :394-401
[98]   OCT1 Expression in Adipocytes Could Contribute to Increased Metformin Action in Obese Subjects [J].
Maria Moreno-Navarrete, Jose ;
Ortega, Francisco J. ;
Rodriguez-Hermosa, Jose-Ignacio ;
Sabater, Monica ;
Pardo, Gerard ;
Ricart, Wifredo ;
Manuel Fernandez-Real, Jose .
DIABETES, 2011, 60 (01) :168-176
[99]   Skin cells and tissue are capable of using L-ergothioneine as an integral component of their antioxidant defense system [J].
Markova, Nelli G. ;
Karaman-Jurukovska, Nevena ;
Dong, Kelly K. ;
Damaghi, Niusha ;
Smiles, Kenneth A. ;
Yarosh, Daniel B. .
FREE RADICAL BIOLOGY AND MEDICINE, 2009, 46 (08) :1168-1176
[100]   Therapeutic implications of renal anionic drug transporters [J].
Masereeuw, Rosalinde ;
Russel, Frans G. M. .
PHARMACOLOGY & THERAPEUTICS, 2010, 126 (02) :200-216